Literature DB >> 22438276

Review of the use of defined daily dose concept in drug utilisation research in China.

Lida Teng1, Hua-wen Xin, Hege Salvesen Blix, Kiichiro Tsutani.   

Abstract

PURPOSE: This study aimed to understand the characteristics of drug utilisation researches (DURs) using concepts of defined daily dose in China and to provide further suggestion for future DURs in China.
METHODS: DURs using concepts of defined daily dose published in China were identified from China Journal Full-text Database, and in-depth data analysis was conducted for DURs published in every even-numbered year.
RESULTS: In total, 2,911 DURs published between 1989 and 2009 were identified, of which 1,268 were included for further data analysis. All studies were hospital-based. Types of drugs commonly assessed in DURs were Anti-infectives for systemic use (34.1%), drugs for Nervous system (25.5%) and drugs for Alimentary tract and metabolism (14.3%). In addition, 63 DURs published in even-numbered year focusing on Chinese Herbal Medicine (CHM) were identified. Commonly used sources of defined dose were Xin Bian Yao Wu Xue/New Materia Medica (83.9%), drug information leaflets (66.8%) and Chinese Pharmacopoeia (52.0%). Common indicators used in DURs include defined daily doses (DDDs), drug utilisation index (DUI) and daily dose cost (DDC).
CONCLUSION: DUR is a popular method to explore the use of both pharmaceutical drugs and CHM in China. The definition of defined daily dose and its related indicators presented in the DURs were highly varied. From this, it follows that DURs with more consistent methodology are highly needed for a thorough understanding of drug utilisation in China. Apart from DURs focusing on the hospital setting, more DURs from other health settings are needed.
Copyright © 2012 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 22438276     DOI: 10.1002/pds.3240

Source DB:  PubMed          Journal:  Pharmacoepidemiol Drug Saf        ISSN: 1053-8569            Impact factor:   2.890


  10 in total

1.  Reserve drug indent form and its impact on antimicrobial consumption and sensitivity pattern in the medical intensive care unit of a tertiary care hospital.

Authors:  Deepthi P Shridhar; K B Anitha; Mohandas Rai; Anisha Fernandes
Journal:  J Clin Diagn Res       Date:  2015-02-01

Review 2.  Indole compounds may be promising medicines for ulcerative colitis.

Authors:  Shinya Sugimoto; Makoto Naganuma; Takanori Kanai
Journal:  J Gastroenterol       Date:  2016-05-09       Impact factor: 7.527

3.  A population-based study comparing biosimilar versus originator erythropoiesis-stimulating agent consumption in 6,117 patients with renal anaemia.

Authors:  Franziska Hörbrand; Peter Bramlage; Johann Fischaleck; Joerg Hasford; Reinhard Brunkhorst
Journal:  Eur J Clin Pharmacol       Date:  2012-10-02       Impact factor: 2.953

4.  Trends in Prescriptions for Insomnia in a Province in China Between 2015 and 2019.

Authors:  Guodong Lou; Zhenwei Yu; Liying Chen; Yiting Zhou; Lisan Zhang
Journal:  Front Psychiatry       Date:  2022-06-20       Impact factor: 5.435

5.  Prescribing efficiency of proton pump inhibitors in China: influence and future directions.

Authors:  Wenjie Zeng; Alexander E Finlayson; Sushma Shankar; Winnie de Bruyn; Brian Godman
Journal:  BMC Health Serv Res       Date:  2015-01-22       Impact factor: 2.655

Review 6.  Systematic review of drug utilization studies & the use of the drug classification system in the WHO-SEARO Region.

Authors:  Sagar S Bachhav; Nilima A Kshirsagar
Journal:  Indian J Med Res       Date:  2015-08       Impact factor: 2.375

7.  Antibiotic consumption study in two hospitals in Asmara from 2014 to 2018 using WHO's defined daily dose (DDD) methodology.

Authors:  Nebyu Daniel Amaha; Dawit G Weldemariam; Yohana H Berhe
Journal:  PLoS One       Date:  2020-07-02       Impact factor: 3.240

8.  Consumption and cost trends of EGFR TKIs: influences of reimbursement and national price negotiation.

Authors:  Di Wu; Jianxiang Xie; Huizhen Dai; Wentong Fang
Journal:  BMC Health Serv Res       Date:  2022-04-01       Impact factor: 2.655

9.  Trends in anti-HER2 drugs consumption and influencing factors.

Authors:  Jie Liu; Xiaolei Zhang; Biao Wang; Huizhen Dai; Dahai Dou; Wentong Fang
Journal:  Front Public Health       Date:  2022-09-08

10.  From population to individuals: a new indicator for evaluating the appropriateness of clinical application of antibiotics.

Authors:  Bin Zheng; Na Li; Zhijian Hu; Maobai Liu
Journal:  BMC Pharmacol Toxicol       Date:  2018-09-05       Impact factor: 2.483

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.